Motherwort — Benefits Deep Dive

Motherwort (Leonurus cardiaca) is a bitter, weedy member of the mint family with an unusually legible history. Its species epithet cardiaca, the German name Herzgespann, and the English folk names throw-wort and lion's tail together record two traditions that ran side by side for centuries: a cardiac one, for the racing, gripped, "nervous" heart, and an obstetric one, for menstruation, labour and the weeks after a birth. These four deep-dive articles cover both, plus the interaction and pregnancy questions that most readers actually need.

Two points belong at the top rather than buried in a safety section, because they are the two ways this herb most commonly goes wrong.

Palpitations need a diagnosis, not a herb. Motherwort's cardiac reputation is genuine and old, and there is some small human and preclinical work on L. cardiaca extract and heart rate, blood pressure and anxiety measures. But there is no adequate controlled trial establishing it as a treatment for any arrhythmia. A racing, irregular, skipping or pounding heartbeat needs a recording of the rhythm. Seek urgent care for palpitations with chest pain, breathlessness, fainting or near-fainting; arrange assessment for palpitations that are sustained or very fast, for palpitations in anyone with a known heart condition or cardiac risk factors, and for new palpitations in later life. Atrial fibrillation and other arrhythmias carry stroke and heart-failure risks that a herb does not address — and the danger does not track how bad the symptom feels.

Pregnancy is a firm contraindication, and the name misleads about it. "Motherwort" and the postpartum tradition lead people to assume the plant is pregnancy-friendly. It is not. Motherwort is a traditional uterine stimulant and emmenagogue and should be avoided in pregnancy, while trying to conceive, and while breastfeeding. This is one of the clearest cases on this site of a common name implying a safety profile the plant does not have.

A note on species that runs through all four pages: Leonurus cardiaca is the European plant behind every English-language product and the EU traditional-use registration, while Leonurus japonicus (yi mu cao) is the heavily used Chinese species that carries most of the genus's pharmacological literature — including nearly all the work on the alkaloid leonurine. The marker constituent of European cardiaca is stachydrine, alongside iridoids, a substantial flavonoid fraction, and the labdane diterpene bitters that make the tea so hard to drink. Every study cited on these pages names its species.

Deep-Dive Articles

Table of Contents

1. Deep-Dive Articles
2. What Motherwort Is
3. The Evidence, Stated Honestly
4. Key Research: Cardiac and Electrophysiological
5. Key Research: Sedative and Psychotropic
6. Key Research: The Human Evidence
7. Key Research: Chemistry and Species Identity
8. Key Research: Safety, Interactions and Pregnancy
9. External Resources
10. Connections

What Motherwort Is

A hardy perennial in the Lamiaceae — the mint family, alongside lemon balm, sage and peppermint — with the family's square stem and opposite leaf pairs, plus its own distinguishing features: ragged, deeply lobed lower leaves and small pale pink to purple flowers in whorls, held in spiny green cups that are genuinely prickly to handle. Native to Central Asia and southeastern Europe, it has naturalised widely across Europe and North America as a roadside and waste-ground weed. The part used is the aerial part: leafy flowering tops harvested as the plant blooms.

Its defining sensory feature is bitterness — motherwort is one of the most punishingly bitter herbs in common use, and that bitterness is the single commonest reason people abandon the tea in favour of a tincture. The taste comes largely from labdane-type diterpenes such as leocardin.

The topic page, Motherwort, covers identification, the origins of the name, forms and dosing, and the general safety picture. These Benefits pages go deeper into four specific questions rather than repeating that ground.

Back to Table of Contents

The Evidence, Stated Honestly

Every claim on these pages carries an evidence tier. Here is the whole picture in one place, so nothing on the individual pages comes as a surprise.

• Randomized clinical trial evidence: none. Not for palpitations, not for any arrhythmia, not for blood pressure, not for anxiety, not for any menstrual, menopausal or postpartum indication. This is the most important line on the page.
• Preliminary human, uncontrolled: one small open-label study of a Leonurus cardiaca oil extract in hypertension accompanied by anxiety and sleep disturbance, reporting improved anxiety scores and modest blood-pressure reduction. No placebo arm, not replicated.
• Preclinical (isolated tissue): L. cardiaca extracts slowed rate and altered cardiac electrophysiology in isolated preparations.
• Preclinical (animal): the isolated glycoside lavandulifolioside reduced heart rate and blood pressure and was sedative; whole modified dry extracts showed psychotropic activity in behavioural testing; analgesic testing in mice was consistent with central depressant activity. Most leonurine work — cardioprotection, neuroprotection, uterine smooth muscle — concerns L. japonicus.
• Traditional use only: the nervous heart and palpitations; nervous tension, restlessness and irritability; delayed or scanty periods; menstrual cramps; premenstrual and menopausal complaints; postpartum uterine involution, afterpains and mood.
• Regulatory status: registered in the European Union as a traditional herbal medicinal product for relief of mild stress-related cardiac symptoms. That status is granted on documented long-standing use and acceptable safety, not on demonstrated efficacy — a distinction routinely blurred in marketing.
• Safety: pregnancy contraindicated; breastfeeding avoided for lack of data; cardiac, sedative and anticoagulant interactions mostly theoretical or preclinical rather than documented in case reports — which, in a population this heavily medicated, argues for caution rather than reassurance.

Back to Table of Contents

Key Research: Cardiac and Electrophysiological

All citations below link to PubMed topic searches, so they return the live literature rather than a single frozen record.

1. Ritter M, Melichar K, Strahler S, et al. Cardiac and electrophysiological effects of primary and refined extracts from Leonurus cardiaca L. Planta Medica, 2010. The central preclinical cardiac paper: extracts prepared to European Pharmacopoeia standards slowed rate and produced electrophysiological changes of the general kind seen with mild antiarrhythmic activity, in isolated preparations. Preclinical (isolated tissue). PubMed: Leonurus cardiaca cardiac electrophysiology
2. Miłkowska-Leyck K, Filipek B, Strzelecka H. Pharmacological effects of lavandulifolioside from Leonurus cardiaca. Journal of Ethnopharmacology, 2002. An isolated phenylethanoid glycoside reduced heart rate and blood pressure — and was sedative — in animal testing. The closest thing to an intact-organism cardiovascular result for a cardiaca constituent. Preclinical (animal). PubMed: lavandulifolioside pharmacology
3. Bernatoniene J, Kopustinskiene DM, Jakstas V, et al. The effect of Leonurus cardiaca herb extract and some of its flavonoids on mitochondrial oxidative phosphorylation in the heart. Planta Medica, 2014. How the herb's flavonoid fraction affects energy handling in cardiac mitochondria. Preclinical. PubMed: Leonurus cardiaca cardiac mitochondria
4. Loh KP, Qi J, Tan BKH, et al. Leonurine protects middle cerebral artery occluded rats through antioxidant effect and regulation of mitochondrial function. Stroke, 2010. Frequently cited as evidence for "motherwort" — but it concerns a purified alkaloid chiefly associated with L. japonicus, in an animal stroke model. Preclinical (animal), different species. PubMed: leonurine neuroprotection
5. Sadowska B, Laskowski D, Bernat P, et al. Molecular mechanisms of Leonurus cardiaca L. extract activity in prevention of staphylococcal endocarditis. Molecules, 2019. Laboratory antibacterial and anti-biofilm work relevant to heart-valve infection — an entirely separate line from the rhythm question. Preclinical (in vitro). PubMed: Leonurus cardiaca and endocarditis

Back to Table of Contents

Key Research: Sedative and Psychotropic

1. Koshovyi O, Raal A, Kireyev I, et al. Phytochemical and psychotropic research of motherwort (Leonurus cardiaca L.) modified dry extracts. Plants, 2021. Chemical characterisation of whole dry extracts paired with animal behavioural testing for sedative and anxiolytic-type activity — closer to a real product than an isolate. Preclinical (animal). PubMed: Leonurus cardiaca psychotropic extracts
2. Miłkowska-Leyck K, Filipek B, Strzelecka H. Pharmacological effects of lavandulifolioside from Leonurus cardiaca. Journal of Ethnopharmacology, 2002. Cited again here because its sedative finding is the single most-referenced piece of support for the calming tradition. Preclinical (animal). PubMed: lavandulifolioside sedative activity
3. Rezaee-Asl M, Sabour M, Nikoui V, et al. The study of analgesic effects of Leonurus cardiaca L. in mice by formalin, tail flick and hot plate tests. International Scholarly Research Notices, 2014. Pain-behaviour testing is sensitive to sedation, so this belongs in the same picture of central depressant activity. Preclinical (animal). PubMed: Leonurus cardiaca analgesic testing
4. Comparative trial literature on herbal anxiolytics — passionflower, lemon balm, valerian and chamomile in controlled human studies. The fair benchmark: several of these have human randomized data, and motherwort has none. PubMed: herbal anxiolytics randomized trials

Back to Table of Contents

Key Research: The Human Evidence

1. Shikov AN, Pozharitskaya ON, Makarov VG, et al. Effect of Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytotherapy Research, 2011. The entire human evidence base for this herb. Dozens of participants, open label, no placebo group, reporting improved anxiety and depression scores and modest blood-pressure reduction — all outcomes highly susceptible to expectation effects. Not replicated in the years since. Preliminary human, uncontrolled. PubMed: Leonurus cardiaca oil extract study
2. Wojtyniak K, Szymański M, Matławska I. Leonurus cardiaca L. (motherwort): a review of its phytochemistry and pharmacology. Phytotherapy Research, 2013. The standard modern survey; catalogues the traditional indications and the absence of trials supporting them. PubMed: Leonurus cardiaca review
3. Fierascu RC, Fierascu I, Ortan A, et al. Leonurus cardiaca L. as a source of bioactive compounds: an update of the European Medicines Agency assessment report. BioMed Research International, 2019. Ties the chemistry and pharmacology to Europe's formal regulatory assessment — and explains why the herb's EU status is traditional use rather than established efficacy. PubMed: Leonurus cardiaca EMA assessment update
4. Searches for anything newer — a properly controlled trial would change these pages substantially, so they are worth re-running: PubMed: Leonurus cardiaca randomized trial and PubMed: motherwort clinical trial.

Back to Table of Contents

Key Research: Chemistry and Species Identity

1. Kuchta K, Ortwein J, Hennig L, et al. Direct quantification of stachydrine in Leonurus japonicus and L. cardiaca by quantitative nuclear magnetic resonance. Fitoterapia, 2014. The reference for the marker alkaloid and for how the two species differ — the analytical basis of the species warning that runs through these pages. PubMed: stachydrine in Leonurus species
2. Agnihotri VK, ElSohly HN, Smillie TJ, et al. New labdane diterpenes from Leonurus cardiaca. Planta Medica, 2008. Isolation of the bitter diterpene constituents that define the plant sensorially and chemically. PubMed: labdane diterpenes Leonurus cardiaca
3. Reviews of Leonurus japonicus (yi mu cao) traditional uses, phytochemistry and pharmacology. The larger literature of the genus sits here, and most leonurine research with it — which is why species attribution matters when reading any claim about "motherwort." PubMed: Leonurus japonicus review
4. Research on leonurine and uterine smooth muscle, largely in L. japonicus preparations and tissue or animal models — the mechanistic root of the genus's uterine-stimulant reputation. PubMed: leonurine uterine smooth muscle
5. Literature on adulteration, misidentification and species authentication in botanical products — the practical reason to buy motherwort that names its species on the label. PubMed: botanical authentication and adulteration

Back to Table of Contents

Key Research: Safety, Interactions and Pregnancy

1. Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. Journal of the American College of Cardiology, 2010. The standard cardiology reference for why a heavily medicated cardiac population is the wrong one for unquantified botanicals. PubMed: herbal products and cardiovascular interactions
2. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs, 2009. The broad systematic picture, including how thin the evidence base is for most botanicals. PubMed: herb-drug interaction systematic review
3. Literature on herbal medicine use in pregnancy and its safety, including reviews of emmenagogue and uterine-stimulant botanicals — the general framework behind motherwort's pregnancy contraindication. PubMed: herbal medicines in pregnancy
4. Literature on herbal medicine use during lactation and the absence of data for most botanicals. PubMed: herbal medicines and breastfeeding
5. Literature on herbal supplements and perioperative risk — bleeding and sedation — which underlies the advice to stop botanicals before surgery. PubMed: herbal supplements and surgery
6. Current safety searches specific to the herb: PubMed: Leonurus cardiaca safety and PubMed: motherwort drug interaction.

Back to Table of Contents

External Resources

• European Medicines Agency — publishes the herbal monograph and assessment report for motherwort herb, including its traditional-use indication and contraindications.
• NCCIH — US National Center for Complementary and Integrative Health; herb-by-herb evidence and safety summaries.
• MedlinePlus — consumer health, drug and supplement information from the US National Library of Medicine.
• NCBI Bookshelf — hosts LactMed, the standard reference for breastfeeding safety.
• American Heart Association — patient information on palpitations, arrhythmias and atrial fibrillation.
• NHS (United Kingdom) — plain-language guidance on heart palpitations, anxiety, and when to seek urgent care.
• American College of Obstetricians and Gynecologists — guidance on pregnancy and postpartum care.
• PubMed: Leonurus cardiaca — the complete live literature on the European species.

Back to Table of Contents

Connections

• All Herbs
• Motherwort for Palpitations
• Motherwort for Anxiety
• Menstrual and Postpartum Tradition
• Motherwort Safety
• Motherwort
• Palpitations
• Heart Palpitations
• Arrhythmia
• Atrial Fibrillation
• Supraventricular Tachycardia
• Hypertension
• Anxiety
• Panic Disorder
• Insomnia
• Postpartum Depression
• Dysmenorrhea
• Perimenopause
• Hyperthyroidism
• Magnesium and Palpitations
• Potassium and Arrhythmia
• Hawthorn Benefits
• Valerian Benefits
• Lemon Balm Benefits
• Passionflower Benefits
• Chamomile
• Skullcap
• L-Theanine
• Cardiology

Safety Note and Disclaimer

These pages are health education, not medical advice. Motherwort has no randomized controlled trial evidence for any indication; its reputation rests on centuries of European tradition, a small preclinical literature, and one small uncontrolled human study. It is not a treatment for any arrhythmia. Palpitations need a diagnosis, not a herb — seek urgent care for palpitations with chest pain, breathlessness, fainting or near-fainting, and arrange assessment for palpitations that are sustained, very fast, irregular, or new in anyone with a heart condition or cardiac risk factors. Motherwort must be avoided in pregnancy, while trying to conceive, and while breastfeeding: it is a traditional uterine stimulant and emmenagogue, and its common name misleadingly suggests otherwise. Do not add it to beta-blockers, other rate-slowing drugs, blood-pressure medication, digoxin, antiarrhythmics, sedatives, antiplatelet drugs or anticoagulants without speaking to your prescriber, and never stop prescribed cardiac medication in order to use a herb. Speak with a qualified clinician before starting any herbal preparation.

Back to Table of Contents